Therapeutic Drug Monitoring: Optimizing Therapy, Minimizing Toxicity
*Corresponding Author:Received Date: Jun 19, 2026 / Published Date: Jul 17, 2026
Citation: Turner M (2026) Therapeutic Drug Monitoring: Optimizing Therapy, Minimizing Toxicity. cpb 15: 587.
Copyright: © 2026 Michael Turner This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Abstract
Therapeutic Drug Monitoring (TDM) is crucial for optimizing drug efficacy and minimizing toxicity through individualized dos ing. Advancements in analytical techniques and PK/PD modeling are expanding its application. Population pharmacokinetic models incorporate patient covariates for refined dosing, while point-of-care testing enables rapid clinical decisions. TDM is vital for im munosuppressants, antibiotics, and psychiatric medications. Integration with pharmacogenomics and the use of machine learning/AI promise further personalization and predictive accuracy. Novel analytical platforms enhance monitoring capabilities, particularly for biologics and targeted therapies. TDM plays a significant role in oncology, optimizing treatment outcomes.
